Japan's Ministry of Health, Labour and Welfare granted orphan drug designation for Pulmovant, which is advancing in Japan.
1 report, 1 independent
Updated Sep 4
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Japan's Ministry of Health, Labour and Welfare granted orphan drug designation for Pulmovant, which is advancing in Japan.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
European Respiratory Society
organization
Nothing else this week.
Coverage
Newest first; wire copies grouped- GlobeNewswirePulmovant Receives Orphan Drug Designation in Japan for Mosliciguat for the Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD) Orphan drug designation from Japan’s